The devotion to surrogate outcomes in drug development for liver disease

Rowe, IA orcid.org/0000-0003-1288-0749 (2018) The devotion to surrogate outcomes in drug development for liver disease. Nature Reviews Gastroenterology and Hepatology, 15 (1). 155. ISSN 1759-5045

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Macmillan Publishers Limited, part of Springer Nature. This is an author produced version of a paper published in Nature Reviews Gastroenterology and Hepatology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Biomarkers, Clinical trials, Drug discovery and development, Liver diseases
Dates:
  • Accepted: 23 October 2017
  • Published (online): 29 November 2017
  • Published: January 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Translational Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 18 Dec 2017 16:19
Last Modified: 29 May 2018 00:38
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1038/nrgastro.2017.155

Export

Statistics


CORE (COnnecting REpositories)